What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need for pharmacologic therapies to treat infected patients, mini...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottaviani, Silvia, Stebbing, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235589/
https://www.ncbi.nlm.nih.gov/pubmed/32838354
http://dx.doi.org/10.1016/j.medj.2020.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235589/
https://www.ncbi.nlm.nih.gov/pubmed/32838354
http://dx.doi.org/10.1016/j.medj.2020.04.002

Ejemplares similares